NCT03326908

Brief Summary

Improvement of retinal medical imaging opens new perspectives for exploring the retinal structures. Optical coherence spectral domain (SD-OCT), which has been widely used in the last ten years, is certainly the most advanced device. In the analysis of patients without retinal disease using SD-OCT, granulations in the interdigitation area were observed. These granulations have never been described with this device. They could correspond either to the degradation products of the external segments of the photoreceptors or to melanosomes. A descriptive study of these granulations at different examination times and in different lighting situations would allow us to obtain essential information for a better understanding of this area. Based on the results, larger studies could explore this area more finely in retinal pathologies involving dysfunctions of photoreceptors or of the pigmentary epithelium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2017

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

October 27, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 31, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2018

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2018

Completed
Last Updated

January 6, 2026

Status Verified

January 1, 2018

Enrollment Period

3 months

First QC Date

October 27, 2017

Last Update Submit

January 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Variation of the number of hyperreflective granulations in the interdigitation area according to time and enlightenment

    1 hour after baseline

Study Arms (2)

Normal conditions of light exposure

OTHER

Spectral Domain Optical Coherence Tomography (SD-OCT): Five SD-OCTs will be produced under the same lighting conditions (photopic). * At baseline * 20 minutes after baseline * 25 minutes after baseline * 45 minutes after baseline * 60 minutes after baseline

Device: Spectral Domain Optical Coherence Tomography

Light variations

OTHER

Spectral Domain Optical Coherence Tomography (SD-OCT): Five SD-OCT will be performed: * at baseline, in a room with photopic artificial lighting (400 lux) * after a period of adaptation to the dark (20 minutes in the dark: 0 lux) * after 5 min of retinal glare, obtained by means of a projection of light of 1000 lux on the fundus of eye * 15 minutes after this period of retinal glare, in photopic artificial lighting * 30 minutes after the period of retinal glare, in photopic artificial lighting

Device: Spectral Domain Optical Coherence Tomography

Interventions

Five SD-OCTs will be performed with various conditions of enlightenment.

Light variationsNormal conditions of light exposure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 18 years or older
  • Consent to participate

You may not qualify if:

  • Retinal abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ophtalmologique A. de Rothschild

Paris, France

Location

Related Publications (1)

  • Mathis T, Vasseur V, Zuber K, Arej N, Loria O, Kodjikian L, Sennlaub F, Mauget-Faysse M. Light-induced modifications of the outer retinal hyperreflective layers on spectral-domain optical coherence tomography in humans: an experimental study. Acta Ophthalmol. 2021 Nov;99(7):765-772. doi: 10.1111/aos.14723. Epub 2021 Jan 4.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2017

First Posted

October 31, 2017

Study Start

October 12, 2017

Primary Completion

January 10, 2018

Study Completion

January 24, 2018

Last Updated

January 6, 2026

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations